A call to bring back sanatoria to help deal with the growing threat of extensively drug-resistant tuberculosis

October 25, 2011

A Viewpoint published Online First by The Lancet calls for new-age sanatoria to be created in countries with a high burden of drug-resistant tuberculosis, in order to deal with the growing threat of extensively-drug resistant tuberculosis (XDR-TB). The Viewpoint is by Professor Keetan Dheda, University of Cape Town, South Africa, and Professor Giovani Miglori, WHO Collaborating Centre for TB and Lung Diseases, Tradate, Italy.

Sanatoria were used across many countries up to the 1970s to help isolate people with tuberculosis from the general community, but were gradually dismantled as living conditions improved, and vaccination and drug treatments arrived, leading to huge falls in infection rates especially in high-income countries. However, years of using the antibiotics rifampicin and isoniazid has led to some half a million cases of multi-drug resistant TB (MDR-TB) globally. Of these, between 25,000 and 50,000 cases are XDR-TB. In high-burden countries such as South Africa, MDR-TB and XDR-TB treatment eats up around half of the TB drug budget, despite only representing a small proportion (1-2%) of total cases. Large numbers of treatment failures occur in XDR-TB cases, and also in many MDR-TB cases, but such patients can survive for months or even years, exposing the community to potential infection. These cases are not responsive to any known treatment (many of them are completely drug-resistant). The authors say that once again, after 60 years, we are faced with TB patients for whom there is no effective treatment.

The authors ask: "How should we deal with these people who are living with failed treatment and who still have the capacity to transmit disease...Is the discharging of these patients, who often live in a single room with many other family members, into impoverished communities justifiable?" They add that the lack of or restricted palliative care facilities means there is nowhere for patients to die in dignified surroundings while infection control in ensured.

This is not just a problem for high-burden, resource-constrained countries. In high-income countries, XDR-TB patients are usually treated in isolation rooms in respiratory or infectious disease departments. But this can mean extremely long hospital stays with no guarantee of successful treatment. Furthermore, soon to be published data from five reference centres in the European Union* show that infection control procedures are far from ideal, exposing other patients and health-care workers to risk of contracting XDR-TB.

The authors advocate for facilities where state-of-the-art palliative care and laboratory facilities can be provided to dying patients in a safe and dignified setting; there, destitute people for whom treatment has failed could voluntarily reside on a long-term basis with social, educational, and recreational facilities, and receive good nutrition and care from support groups and a multidisciplinary team within an infection-controlled setting, thereby reducing transmission within the community and to family members, including children.

They conclude: "The time for rebuilding so-called new sanatoria under a new vision has come and is overdue...We have now come full circle and once again there are large numbers of patients for whom there are no effective antituberculosis drugs. The pool of untreatable cases is accumulating and will need swift action to avoid a human catastrophe."
-end-
Professor Keetan Dheda, University of Cape Town Lung Institute, South Africa. T) +27 21 406 7650 / +27 845577754 E) keertan.dheda@uct.ac.za

Professor Giovani Miglori, WHO Collaborating Centre for TB and Lung Diseases, Tradate, Italy. E) giovannibattista.migliori@fsm.it

Note to editors*: The 5 EU Countries cannot be disclosed as per ECDC policy, but they include 2 central European EU countries, 2 western EU countries at low incidence, and 1 western EU country at intermediate incidence. Please contact the ECDC tuberculosis programme with any enquiries on this point: emma.huitric@ecdc.europa.eu

Lancet

Related Tuberculosis Articles from Brightsurf:

Scientists find new way to kill tuberculosis
Scientists have discovered a new way of killing the bacteria that cause tuberculosis (TB), using a toxin produced by the germ itself.

Blocking the iron transport could stop tuberculosis
The bacteria that cause tuberculosis need iron to survive. Researchers at the University of Zurich have now solved the first detailed structure of the transport protein responsible for the iron supply.

Tuberculosis: New insights into the pathogen
Researchers at the University of W├╝rzburg and the Spanish Cancer Research Centre have gained new insights into the pathogen that causes tuberculosis.

Unmasking the hidden burden of tuberculosis in Mozambique
The real burden of tuberculosis is probably higher than estimated, according to a study on samples from autopsies performed in a Mozambican hospital.

HIV/tuberculosis co-infection: Tunneling towards better diagnosis
1.2 million people in the world are co-infected by the bacteria which causes tuberculosis and AIDS.

Reducing the burden of tuberculosis treatment
A research team led by MIT has developed a device that can lodge in the stomach and deliver antibiotics to treat tuberculosis, which they hope will make it easier to cure more patients and reduce health care costs.

Tuberculosis: Commandeering a bacterial 'suicide' mechanism
The bacteria responsible for tuberculosis can be killed by a toxin they produce unless it is neutralized by an antidote protein.

A copper bullet for tuberculosis
Tuberculosis is a sneaky disease, and the number one cause of death from infectious disease worldwide.

How damaging immune cells develop during tuberculosis
Insights into how harmful white blood cells form during tuberculosis infection point to novel targets for pharmacological interventions, according to a study published in the open-access journal PLOS Pathogens by Valentina Guerrini and Maria Laura Gennaro of Rutgers New Jersey Medical School, and colleagues.

How many people die from tuberculosis every year?
The estimates for global tuberculosis deaths by the World Health Organisation (WHO) and the Institute for Health Metrics and Evaluation (IHME) differ considerably for a dozen countries, according to a study led by ISGlobal.

Read More: Tuberculosis News and Tuberculosis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.